Advarra, a private equity-backed consolidator of IRBs as well as technology and clinical service vendors, has announced its intent to acquire leading academic research center focused vendor Forte. Their OnCore enterprise research software has been adopted by many large academic medical centers. The combined organization leverages mutual strengths in supporting the research community with the client, regulatory expertise, and technology-enabled efficiencies to accelerate innovation, streamline research operations, support faster study start-up and help improve overall research productivity. The acquisition bolsters its position for intensified competition against rival WCG.
Forte has been a leading provider of the academic research center and site solution technology including electronic data capture, document management, study management, and reporting. Private equity infused capital (and took ownership) in the Wisconsin-based enterprise back in 2015. The Forte Solution Stack includes 1) Clinical Trial Management 2) Clinical Data Management and 3) Research Administration. What follows is a brief summary of their solutions.
Clinical Trial Management (CTM)
The core of their CTM suite is Oncore, an enterprise research system used by hundreds of research centers including many of the largest academic medical systems. Other solutions include A) Insights (business intelligence); B) eReg (regulatory management such as reg binders); C) Payments (automated site payments) and D) benchmarks (comparative analytics.
Clinical Data Management (CDM)
Forte’s CDM solution is built on their EDC solution (electronic data capture) which they tout is integrated with OnCore CTMS and equipped with a lab results interface via FHIR.
Research Administration (RA)
Forte’s RA solution is centered on A) Eval for showcasing the value of research to funders such as the NIH and B) Insights, their business intelligence solution.
Forte vs. Velos
In January 2019 WCG acquired the Velos eResearch platform for their clinical trials management software tools. Now that Advarra has announced its Forte deal they will incorporate these technology solutions (and client base) leverage for upsells/cross-sells and more intensively against WCG (Velos) and other vendors from best-of-breed solution providers to integrated CROs.
Call to Action: Are you looking at making comparisons between WCG software products and Advarra products—feel free to contact TrialSite News as we have a lot of information about these systems. We will be happy to share what we know.